Literature DB >> 19010830

Proliferation imaging to measure early cancer response to targeted therapy.

David A Mankoff1, Janet F Eary.   

Abstract

Positron emission tomography imaging using thymidine and analogues labeled with positron emitters provides noninvasive and quantitative estimates of regional cellular proliferation. This CCR Translations summary reviews the biological basis for proliferation imaging and discusses recent results using 18F-fluorothymidine-positron emission tomography to measure response to targeted therapy in the context of prior studies and potential future applications.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19010830     DOI： 10.1158/1078-0432.CCR-08-2233

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  4 in total

1.  Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome.

Authors:  Ian Ganly; Jennifer Bocker; Diane L Carlson; Salvatore D'Arpa; Maria Coleman; Nancy Lee; David G Pfister; Jatin P Shah; Snehal G Patel
Journal:  Head Neck       Date:  2010-11-04       Impact factor: 3.147

Review 2.  Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents.

Authors:  Jingjuan Qiao; Shenghui Xue; Fan Pu; Natalie White; Jie Jiang; Zhi-Ren Liu; Jenny J Yang
Journal:  J Biol Inorg Chem       Date:  2013-12-24       Impact factor: 3.358

Review 3.  Advances in molecular imaging for breast cancer detection and characterization.

Authors:  Jennifer M Specht; David A Mankoff
Journal:  Breast Cancer Res       Date:  2012-03-16       Impact factor: 6.466

4.  Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.

Authors:  Austin R Pantel; Varsha Viswanath; Mark Muzi; Robert K Doot; David A Mankoff
Journal:  J Nucl Med       Date:  2022-04       Impact factor: 11.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.